Corbus Pharmaceuticals Holdings (CRBP) Treasury Shares (2023)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Treasury Shares of $17911.0 in Q4 2023, down 26.17% quarter-over-quarter from $24259.0 in Q3 2023.
Corbus Pharmaceuticals Holdings (CRBP) Treasury Shares (2023) Analysis & Trends
Corbus Pharmaceuticals Holdings' Treasury Shares history runs 1 years deep, the most recent figure standing at $17911.0 for Q4 2023.
- In Q4 2023, Treasury Shares changed N/A year-over-year to $17911.0; the TTM figure through Dec 2023 stood at $17911.0 (changed N/A YoY), while the FY2023 annual figure was $17911.0, changed N/A from the prior year.
- Treasury Shares was $17911.0 for Q4 2023 at Corbus Pharmaceuticals Holdings, down from $24259.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $24259.0 in Q3 2023 to a low of $17911.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17,911.00 |
| Dec 31, 2023 | 17,911.00 |
| Sep 30, 2023 | 24,259.00 |
| Sep 30, 2023 | 24,259.00 |
| Jun 30, 2023 | 21,342.00 |
| Jun 30, 2023 | 21,342.00 |
| Mar 31, 2023 | 23,990.00 |
| Mar 31, 2023 | 23,990.00 |